Back
Rafarma Pharmaceuticals Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
RAFA
Rafarma Pharmaceuticals
Last Price:
$0.1400
Seasonality Move:
176.06%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and RAFA is experiencing slight buying pressure.
Rafarma Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.14 | Buy |
20-day SMA: | 0.14 | Sell |
50-day SMA: | 0.14 | Sell |
200-day SMA: | 0.09 | Buy |
8-day EMA: | 0.14 | Buy |
20-day EMA: | 0.14 | Sell |
50-day EMA: | 0.14 | Buy |
200-day EMA: | 0.12 | Buy |
Rafarma Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.21 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.1278 - 0.1678) | Sell |
Bollinger Bands (100): | (0.0885 - 0.1485) | Buy |
Rafarma Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rafarma Pharmaceuticals Stock
Is Rafarma Pharmaceuticals Stock a Buy?
-
Rafarma Pharmaceuticals share price is 0.1396 while RAFA 8-day simple moving average is 0.1371, which is a Buy signal.
-
The stock price of RAFA is 0.1396 while Rafarma Pharmaceuticals 20-day SMA is 0.1441, which makes it a Sell.
-
Rafarma Pharmaceuticals 50-day simple moving average is 0.1434 while RAFA share price is 0.1396, making it a Sell technically.
-
RAFA stock price is 0.1396 and Rafarma Pharmaceuticals 200-day simple moving average is 0.0874, creating a Buy signal.
RAFA Technical Analysis vs Fundamental Analysis
Sell
43
Rafarma Pharmaceuticals (RAFA)
is a Sell
Is Rafarma Pharmaceuticals a Buy or a Sell?
-
Rafarma Pharmaceuticals stock is rated a SellThe current Rafarma Pharmaceuticals [RAFA] share price is $0.1396. The Score for RAFA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Rafarma Pharmaceuticals Stock Info
Market Cap:
11.7M
Price in USD:
0.1396
Share Volume:
0
Rafarma Pharmaceuticals 52-Week Range
52-Week High:
0.1790
52-Week Low:
0.0330
Sell
43
Rafarma Pharmaceuticals (RAFA)
is a Sell
Rafarma Pharmaceuticals Share Price Forecast
-
What is the Rafarma Pharmaceuticals stock price today?The Rafarma Pharmaceuticals stock price is 0.1396 USD today.
-
Will RAFA stock go up or go down?Rafarma Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rafarma Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rafarma Pharmaceuticals is overvalued.
Is Rafarma Pharmaceuticals Stock a Buy?
-
Rafarma Pharmaceuticals share price is 0.1396 while RAFA 8-day exponential moving average is 0.1368, which is a Buy signal.
-
The stock price of RAFA is 0.1396 while Rafarma Pharmaceuticals 20-day EMA is 0.1418, which makes it a Sell.
-
Rafarma Pharmaceuticals 50-day exponential moving average is 0.1360 while RAFA share price is 0.1396, making it a Buy technically.
-
RAFA stock price is 0.1396 and Rafarma Pharmaceuticals 200-day simple moving average is 0.1175, creating a Buy signal.
Technical Analysis of Rafarma Pharmaceuticals
Should I short Rafarma Pharmaceuticals stock?
-
RAFA Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Rafarma Pharmaceuticals is a Sell
-
Rafarma Pharmaceuticals Relative Strength Index (RSI) is 49.21, which suggest Rafarma Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rafarma Pharmaceuticals is (0.1278 - 0.1678), which suggest Rafarma Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rafarma Pharmaceuticals is (0.0885 - 0.1485), which suggest Rafarma Pharmaceuticals is a Buy
* Rafarma Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.